These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 12418035

  • 21. Does evidence-based medicine provide evidence? The evidence on breast cancer and the safety of oral contraceptives suggests that unorthodox interpretations may be just as valid.
    Reynolds TM, Wierzbicki AS.
    Breast J; 2003; 9(1):66-7. PubMed ID: 12558680
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Oral contraceptives and the risk of death from breast cancer.
    Wingo PA, Austin H, Marchbanks PA, Whiteman MK, Hsia J, Mandel MG, Peterson HB, Ory HW.
    Obstet Gynecol; 2007 Oct; 110(4):793-800. PubMed ID: 17906011
    [Abstract] [Full Text] [Related]

  • 24. [The pill and cancer of the breast].
    Gest J.
    Bull Cancer; 1990 Oct; 77(1):1-3. PubMed ID: 2317571
    [No Abstract] [Full Text] [Related]

  • 25. Hormone replacement therapy and the risk of breast cancer.
    Cuzick J.
    Eur J Cancer; 2008 Nov; 44(16):2344-9. PubMed ID: 18783940
    [Abstract] [Full Text] [Related]

  • 26. [Breast cancer and the use of hormones around menopause].
    Boukes FS, Groeneveld FP, Goudswaard AN.
    Ned Tijdschr Geneeskd; 2004 Jun 05; 148(23):1170. PubMed ID: 15211974
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Shah NR.
    Cancer; 2003 Oct 01; 98(7):1552-3; author reply 1553. PubMed ID: 14508845
    [No Abstract] [Full Text] [Related]

  • 30. Estrogens and breast cancer.
    Blander CL.
    N Engl J Med; 2006 Apr 13; 354(15):1647-8; author reply 1647-8. PubMed ID: 16611962
    [No Abstract] [Full Text] [Related]

  • 31. Hormone therapy and breast cancer: what factors modify the association?
    Gertig DM, Fletcher AS, English DR, Macinnis RJ, Hopper JL, Giles GG.
    Menopause; 2006 Apr 13; 13(2):178-84. PubMed ID: 16645531
    [Abstract] [Full Text] [Related]

  • 32. Antiperspirant use as a risk factor for breast cancer in Iraq.
    Fakri S, Al-Azzawi A, Al-Tawil N.
    East Mediterr Health J; 2006 Apr 13; 12(3-4):478-82. PubMed ID: 17037719
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Oral contraception and some debatable side effects.
    Astedt B.
    Acta Obstet Gynecol Scand Suppl; 1982 Apr 13; 105():17-23. PubMed ID: 7044021
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Oral contraceptives and breast-cancer rates.
    Wiseman RA.
    Lancet; 1984 Apr 07; 1(8380):791. PubMed ID: 6143102
    [No Abstract] [Full Text] [Related]

  • 37. [Breast cancer and the use of the hormones around the menopause].
    van der Mooren MJ, Kenemans P.
    Ned Tijdschr Geneeskd; 2004 May 15; 148(20):1009-10; author reply 1010-1. PubMed ID: 15181729
    [No Abstract] [Full Text] [Related]

  • 38. Oral-contraceptive use and the risk of breast cancer.
    N Engl J Med; 1987 Jan 15; 316(3):162-4. PubMed ID: 3796688
    [No Abstract] [Full Text] [Related]

  • 39. Combined estradiol/gestodene and acute pancreatitis.
    Trenque-Tessereau MG, Picot C, Herment N, Trenque TC.
    Ann Pharmacother; 2005 Nov 15; 39(11):1953-4. PubMed ID: 16204389
    [No Abstract] [Full Text] [Related]

  • 40. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L, Dell'Aniello S, Assouline S, Suissa S.
    BJOG; 2008 Jan 15; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.